Details

Autor(en) / Beteiligte

• Zhou, Yan
• Liu, Cheng-Hui
• Wu, Binlin
• Yu, Xinguang
• Cheng, Gangge
• Zhu, Ke
• Wang, Kai
• Zhang, Chunyuan
• Zhao, Mingyue
• Zong, Rui
• Zhang, Lin
• Shi, Lingyan
• Alfano, Robert R

Titel

Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy

Ist Teil von

• Journal of biomedical optics, 2019-09, Vol.24 (9), p.095001-095001

Ort / Verlag

United States: Society of Photo-Optical Instrumentation Engineers

Erscheinungsjahr

2019

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Glioma is one of the most refractory types of brain tumor. Accurate tumor boundary identification and complete resection of the tumor are essential for glioma removal during brain surgery. We present a method based on visible resonance Raman (VRR) spectroscopy to identify glioma margins and grades. A set of diagnostic spectral biomarkers features are presented based on tissue composition changes revealed by VRR. The Raman spectra include molecular vibrational fingerprints of carotenoids, tryptophan, amide I/II/III, proteins, and lipids. These basic in situ spectral biomarkers are used to identify the tissue from the interface between brain cancer and normal tissue and to evaluate glioma grades. The VRR spectra are also analyzed using principal component analysis for dimension reduction and feature detection and support vector machine for classification. The cross-validated sensitivity, specificity, and accuracy are found to be 100%, 96.3%, and 99.6% to distinguish glioma tissues from normal brain tissues, respectively. The area under the receiver operating characteristic curve for the classification is about 1.0. The accuracies to distinguish normal, low grade (grades I and II), and high grade (grades III and IV) gliomas are found to be 96.3%, 53.7%, and 84.1% for the three groups, respectively, along with a total accuracy of 75.1%. A set of criteria for differentiating normal human brain tissues from normal control tissues is proposed and used to identify brain cancer margins, yielding a diagnostic sensitivity of 100% and specificity of 71%. Our study demonstrates the potential of VRR as a label-free optical molecular histopathology method used for in situ boundary line judgment for brain surgery in the margins.